Illumina Stock Price and Value Analysis

Should you buy Illumina stock? (NasdaqGS:ILMN). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ILMN Numbers

ILMN Price
(Illumina stock price per share)
$486.52
[?] ILMN Fair Price
(based on intrinsic value)
$55.58
[?] ILMN Safety Price (based on a variable margin of safety) $33.35
[?] PE Ratio versus Sector 460% higher than other Healthcare stocks
[?] PE Ratio versus Industry 15% lower than other Diagnostics & Research stocks
[?] Cash Yield 0.83%
[?] Free Cash Flow Jitter 45%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,898,061 shares shorted. With 145,519,660 shares available for purchase and an average trading volume over the past 10 trading days of 599,828, it would take at least 4.831 days for all of the short holders to cover their shorts.

Is Illumina Stock on Sale?

We believe that Illumina may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Illumina looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy ILMN Stock?

Does Illumina have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.